Survey to determine the prevalence of the use of illicit drugs, alcohol, prescription drugs and gambling in the general population

The Health Research Board

General Population Survey 2018/19.
Prevalence and patterns of drug use among the general population, measured by probabilistic surveys of the adult and school population, is one of five EMCDDA key indicators that assess the drugs situation and allow monitoring of progress towards EU and Member State drug policy targets. The aim of this key indicator is to provide valid, reliable and comparable information on the extent, the distribution and the patterns of drug use in the general population (adults and young people), the characteristics of drug users and their perceptions. Each Member State is required to complete a regular survey to estimate national drug use prevalence and Ireland has conducted four of these general population surveys (2002/03, 2006/07, 20010/11 and 2014/15).

Deadline

The time limit for receipt of tenders was 2018-06-25. The procurement was published on 2018-05-18.

Suppliers

The following suppliers are mentioned in award decisions or other procurement documents:

Who? What? Where?
Procurement history
Date Document
2018-05-18 Contract notice
2018-11-22 Contract award notice
Contract notice (2018-05-18)
Object
Scope of the procurement
Title: Survey conduction services
Reference number: HRB 2018 - Gen Pop Survey
Short description:
General Population Survey 2018/19. Prevalence and patterns of drug use among the general population, measured by probabilistic surveys of the adult and school population, is one of five EMCDDA key indicators that assess the drugs situation and allow monitoring of progress towards EU and Member State drug policy targets. The aim of this key indicator is to provide valid, reliable and comparable information on the extent, the distribution and the patterns of drug use in the general population (adults and young people), the characteristics of drug users and their perceptions. Each Member State is required to complete a regular survey to estimate national drug use prevalence and Ireland has conducted four of these general population surveys (2002/03, 2006/07, 20010/11 and 2014/15).
Show more
Notice metadata
Original language: English ๐Ÿ—ฃ๏ธ
Document type: Contract notice
Nature of contract: Services
Regulation: European Union
Common procurement vocabulary (CPV)
Code: Survey conduction services ๐Ÿ“ฆ
Additional CPV: Survey services ๐Ÿ“ฆ
Place of performance
NUTS region: ร‰ire/Ireland ๐Ÿ™๏ธ

Procedure
Procedure type: Open procedure
Type of bid: Submission for all lots
Award criteria
The most economic tender

Contracting authority
Identity
Country: Ireland ๐Ÿ‡ฎ๐Ÿ‡ช
Awarding authority type: Ministry or any other national or federal authority
Awarding authority name: The Health Research Board
Postal address: 67-72 Grattan House
Postal code: Lower Mount St
Postal town: Dublin 2
Contact
Internet address: http://www.hrb.ie ๐ŸŒ
E-mail: dmurphy@hrb.ie ๐Ÿ“ง
Phone: +353 12345215 ๐Ÿ“ž
URL for documents: http://irl.eu-supply.com/app/rfq/rwlentrance_s.asp?PID=129415&B=ETENDERS_SIMPLE ๐ŸŒ
URL for participation: http://irl.eu-supply.com/app/rfq/rwlentrance_s.asp?PID=129415&B=ETENDERS_SIMPLE ๐ŸŒ

Reference
Dates
Date dispatched: 2018-05-18 ๐Ÿ“…
Submission deadline: 2018-06-25 ๐Ÿ“…
Publication date: 2018-05-23 ๐Ÿ“…
Start date: 2018-07-10 ๐Ÿ“…
End date: 2019-07-09 ๐Ÿ“…
Identifiers
Notice number: 2018/S 096-219063
OJ-S issue: 96

Object
Scope of the procurement
Short description:
General Population Survey 2018/19.
Prevalence and patterns of drug use among the general population, measured by probabilistic surveys of the adult and school population, is one of five EMCDDA key indicators that assess the drugs situation and allow monitoring of progress towards EU and Member State drug policy targets. The aim of this key indicator is to provide valid, reliable and comparable information on the extent, the distribution and the patterns of drug use in the general population (adults and young people), the characteristics of drug users and their perceptions. Each Member State is required to complete a regular survey to estimate national drug use prevalence and Ireland has conducted four of these general population surveys (2002/03, 2006/07, 20010/11 and 2014/15).
Show more
Estimated total value: 575 000 EUR ๐Ÿ’ฐ
Short description:
The Health Research Board (HRB) is the lead agency in Ireland supporting and funding health research. We provide funding, maintain health information systems and conduct research linked to national health priorities. Our aim is to improve people's health, build health research capacity and make a significant contribution to Ireland's knowledge economy. Our latest Corporate Strategy clearly outlines how we hope to achieve this working in partnership with other organizations.
Show more
Prevalence and patterns of drug use among the general population, measured by probabilistic surveys of the adult and school population, is one of five EMCDDA key indicators that assess the drugs situation and allow monitoring of progress towards EU and Member State drug policy targets. The aim of this key indicator is to provide valid, reliable and comparable information on the extent, the distribution and the patterns of drug use in the general population (adults and young people), the characteristics of drug users and their perceptions. Each Member State is required to complete a regular survey to estimate national drug use prevalence and Ireland has conducted four of these general population surveys (2002/03, 2006/07, 20010/11 and 2014/15).1 Previous surveys were conducted simultaneously in Ireland and Northern Ireland (on behalf of the Public Health Information and Research Branch (PHIRB), within the Department of Health, Social Services and Public Safety). The 2018/19 survey will be conducted in Ireland only.
Show more
1) Survey brief
The Health Research Board will commission a fifth survey, to be completed between September 2018 and April 2019. The survey will require a nationally representative proability sample of the persons aged 15 years and over and resident in households in Ireland. The sample size will be in the order of 8,302. The survey will use a pre-prepared questionnaire and interviews will be conducted face-to-face in respondentsโ€™ homes using CAPI.
Show more
Estimated value excluding VAT: 575 000 EUR ๐Ÿ’ฐ

Procedure
Time of receipt of tenders: 12:00
Languages in which tenders or requests to participate may be submitted: English ๐Ÿ—ฃ๏ธ
Tender validity period: 12 months
Tender opening date: 2018-06-25 ๐Ÿ“…
Tender opening time: 12:00

Contracting authority
Identity
National registration number: N/a
Contact
Contact point: Dara Murphy
Internet address: www.hrb.ie ๐ŸŒ
Address of the buyer profile: https://irl.eu-supply.com/ctm/Company/CompanyInformation/Index/261 ๐ŸŒ
Documents URL: http://irl.eu-supply.com/app/rfq/rwlentrance_s.asp?PID=129415&B=ETENDERS_SIMPLE ๐ŸŒ

Complementary information
Review body
Name: High Court
Postal address: Chief Registrar, The Four Courts
Postal town: Dublin
Postal code: 7
Country: Ireland ๐Ÿ‡ฎ๐Ÿ‡ช
Phone: +353 18886000 ๐Ÿ“ž
E-mail: highcourtcentraloffice@courts.ie ๐Ÿ“ง
Source: OJS 2018/S 096-219063 (2018-05-18)
Contract award notice (2018-11-22)
Object
Scope of the procurement
Short description:
General Population Survey 2018/19. Prevalence and patterns of drug use among the general population, measured by probabilistic surveys of the adult and school population, is 1 of 5 EMCDDA key indicators that assess the drugs situation and allow monitoring of progress towards EU and Member State drug policy targets. The aim of this key indicator is to provide valid, reliable and comparable information on the extent, the distribution and the patterns of drug use in the general population (adults and young people), the characteristics of drug users and their perceptions. Each Member State is required to complete a regular survey to estimate national drug use prevalence and Ireland has conducted four of these general population surveys (2002/03, 2006/07, 20010/11 and 2014/15).
Show more
Total value of the procurement: 574 675 EUR ๐Ÿ’ฐ
Notice metadata
Document type: Contract award notice

Procedure
Type of bid: Not applicable

Reference
Dates
Date dispatched: 2018-11-22 ๐Ÿ“…
Publication date: 2018-11-27 ๐Ÿ“…
Identifiers
Notice number: 2018/S 228-522055
Refers to notice: 2018/S 096-219063
OJ-S issue: 228

Object
Scope of the procurement
Short description:
Prevalence and patterns of drug use among the general population, measured by probabilistic surveys of the adult and school population, is 1 of 5 EMCDDA key indicators that assess the drugs situation and allow monitoring of progress towards EU and Member State drug policy targets. The aim of this key indicator is to provide valid, reliable and comparable information on the extent, the distribution and the patterns of drug use in the general population (adults and young people), the characteristics of drug users and their perceptions. Each Member State is required to complete a regular survey to estimate national drug use prevalence and Ireland has conducted four of these general population surveys (2002/03, 2006/07, 20010/11 andโ€ฆ
โ€ฆ 2014/15).
โ€ฆ 2014/15). 1 Previous surveys were conducted simultaneously in Ireland and Northern Ireland (on behalf of the Public Health Information and Research Branch (PHIRB), within the Department of Health, Social Services and Public Safety). The 2018/19 survey will be conducted in Ireland only.
1) Survey brief:
The Health Research Board will commission a fifth survey, to be completed between September 2018 and April 2019. The survey will require a nationally representative proability sample of the persons aged 15 years and over and resident in households in Ireland. The sample size will be in the order of 8 302. The survey will use a pre-prepared questionnaire and interviews will be conducted face-to-face in respondentsโ€™ homes using CAPI.
Show more

Procedure
Award criteria
Quality criterion (name): Experience in managing large population surveys
Quality criterion (weighting): 35 %
Quality criterion (name): Qualifications of staff assigned to this project
Quality criterion (weighting): 10 %
Quality criterion (name): Ability to deliver key outputs to a tight deadline
Understanding of the requirements of the contract and feasibility of the proposed plan
Clarity in outlining the proposed plan, including details around milestones and data analysis
Quality criterion (weighting): 10
Price (weighting): 25 %

Award of contract
Date of contract conclusion: 2018-09-28 ๐Ÿ“…
Name: Ipsos MRBI / MRBI Market Research Ltd
National registration number: 9701145N
Postal address: Block 3 Blackrock Business Park
Postal town: Co Dublin
Postal code: Carysfort Avenue, Bl
Country: Ireland ๐Ÿ‡ฎ๐Ÿ‡ช
Phone: +353 14389048 ๐Ÿ“ž
E-mail: kieran.oleary@ipsos.com ๐Ÿ“ง
Internet address: http://www.ipsosmrbi.com ๐ŸŒ
Total value of the procurement: 574 675 EUR ๐Ÿ’ฐ
Information about tenders
Number of tenders received: 4
Source: OJS 2018/S 228-522055 (2018-11-22)